Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Cooley LLP’ returned 3,207 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Productwise 3-2-1

    Here's the next edition of our monthly bite-sized digest, Productwise 3-2-1 where each month, we'll be bringing to the top of your inbox (and your agenda):
    United StatesConsumer Protection
    Cooley LLP
    Cooley LLP
  • Article

    Rejection Time: On February 20th The Supreme Court Hears Oral Argument On The Big Question In The Tempnology Case — Does A Trademark Licensee Lose Its Rights Upon Rejection?

    The Big Question. What is the effect of rejection of a trademark license by a debtor-licensor? Over the past few years, this blog has followed the Tempnology case out of New Hampshire raising just that issue.
    United StatesIntellectual Property
    Cooley LLP
    Cooley LLP
  • Article

    European Commission Issues UK Adequacy Decisions

    On 28 June 2021, the European Commission issued two adequacy decisions in respect of the UK – one under Regulation (EU) 2016/679 (the EU's General Data Protection Regulation, or EU GDPR) and ...
    European UnionPrivacy
    Cooley LLP
    Cooley LLP
  • Article

    Disruption Caused By COVID-19

    We all hope that the predictions about the spread and seriousness of COVID-19 (coronavirus) prove to be unfounded.
    GlobalCompliance
    Cooley LLP
    Cooley LLP
  • Article

    EPO Extends Most Deadlines In Response To COVID‑19 Pandemic

    The European Patent Office (EPO) has announced that it will be extending some deadlines to 17 April 2020, and that this date may be further extended.
    United KingdomCoronavirus (COVID-19)
    Cooley LLP
    Cooley LLP
  • Article

    UK National Security And Investment Bill Receives Royal Ascent

    On 29 April 2021, the UK National Security and Investment Bill, which strengthens the UK government's ability to investigate transactions on grounds of national security, was granted Royal Ascent.
    United KingdomGovernment, Public Sector
    Cooley LLP
    Cooley LLP
  • Article

    SBA Programs Under The CARES Act: ‘Affiliation' Interim Final Rules And Guidance

    A key feature of the CARES Act $2 trillion relief package is the creation of the Paycheck Protection Program (PPP), which authorizes $349 billion for businesses to obtain loans of up to $10 million...
    United StatesCoronavirus (COVID-19)
    Cooley LLP
    Cooley LLP
  • Article

    Corp Fin Posts Sample Comment Letter On XBRL

    Corp Fin has posted a sample comment letter to companies about their XBRL disclosures. I don't pretend to know or understand a thing about XBRL, much less Inline XBRL...
    United StatesCorporate/Commercial Law
    Cooley LLP
    Cooley LLP
  • Article

    Corp Fin Urges Redaction Of Personally Identifiable Information From Rule 14a-8 Submissions

    The staff tries to redact this information before making the materials publicly available, but that process can delay posting of these materials.
    United StatesCorporate/Commercial Law
    Cooley LLP
    Cooley LLP
  • Article

    CMS Releases Guidance Allowing Step Therapy For Part B Drugs

    Today, the Centers for Medicare & Medicaid Services (CMS) released guidance and a Fact Sheet that will provide Medicare Advantage (MA) plans the option of utilizing "step therapy"
    United StatesFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Article

    Cash for the Crash

    With uncertainty continuing surrounding the UK's proposed exit from the EU, the UK government is offering grants of £25,000 or more to help UK businesses prepare for the implications of a "no-deal"
    United StatesGovernment, Public Sector
    Cooley LLP
    Cooley LLP
  • Article

    Trials And Tribulations: Minimising The Risk Of Disputes Arising From Clinical Trial Agreements

    The Clinical Trials Regulation (‘CTR'), which came into force last year, has modified (and in some cases increased) responsibilities for sponsors, streamlined reporting processes...
    United StatesLitigation, Mediation & Arbitration
    Cooley LLP
    Cooley LLP
  • Article

    Inundated With Requests Under New Jersey's Daniel's Law?

    A flood of class action lawsuits have been filed against companies alleging violations of New Jersey's Daniel's Law.
    United StatesPrivacy
    Cooley LLP
    Cooley LLP
  • Article

    Transitional Tax Reporting Guidance For Business Transactions Involving Digital Assets

    In Announcement 2024-4, the IRS and the US Department of the Treasury stated that, until regulations are issued, taxpayers will not be required to treat digital assets received in the course of their trade or business as cash.
    United StatesTax
    Cooley LLP
    Cooley LLP
  • Article

    Public Companies Update – April One-Minute Reads

    On March 14, 2023, the Securities and Exchange Commission announced settled charges against DXC Technology, an IT services company...
    United StatesCompliance
    Cooley LLP
    Cooley LLP
  • Article

    Cooley's 2019 Tech M&A Year In Review

    In the wake of record-setting volume and value metrics in 2018, practitioners eyed the 2019 deal market with healthy skepticism.
    United StatesCorporate/Commercial Law
    Cooley LLP
    Cooley LLP
  • Article

    Productwise 3-2-1 (August, 2020)

    Here's the next edition of our monthly bite-sized digest, Productwise 3-2-1 where each month, we'll be bringing to the top of your inbox (and your agenda):
    United StatesConsumer Protection
    Cooley LLP
    Cooley LLP
  • Article

    Productwise 3-2-1 (29 October 2021)

    Productwise 3-2-1, our monthly bite-sized digest of the current key issues in products law.
    GlobalConsumer Protection
    Cooley LLP
    Cooley LLP
  • Article

    The Beginning Of A Process: How Europe's New Consumer Agenda Will Reshape The Future Of Product Regulation

    "It's the beginning of a process, not the end". These are the words of European Commissioner for Justice, Didier Reynders this week, when answering questions from the European Parliament...
    European UnionConsumer Protection
    Cooley LLP
    Cooley LLP
  • Article

    European Commission Publishes Updated Q&A On Clinical Trials Regulation

    In December 2022, the European Commission published an updated version of the Q&A guidance on the Clinical Trials Regulation.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Showing 661–680 of 3207 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics